| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Muhanad Elnoor, Syed Ali Bokhari, Meghana Singh, Idriss A Mohame. Effectiveness of Vitamin E in Treatment of Antipsychotic-Induced Tardive Dyskinesia and Extrapyramidal Symptoms: A Case Report. Cureus. vol 16. issue 8. 2024-09-30. PMID:39347240. |
the patient, who had been receiving paliperidone injections as part of his psychotic disorder treatment regimen, developed marked eps, including muscle rigidity, a parkinsonian gait, significant motor disturbances as well as tardive dyskinesia. |
2024-09-30 |
2024-10-02 |
Not clear |
| Milena Stojkovic, Mirjana Jovanovic, Vladimir Jakovljevic, Vladimir Zivkovic, Natasa Djordjevic, Aleksandar Kocovic, Marina Nikolic, Aleksandra Stojanovic, Natasa Minic, Vesna Ignjatovic, Vladimir Vukomanovic, Danijela Nastic, Natasa Zdravkovic, Olivera Radmanovic, Milan Djordjic, Sasa Babic, Branimir Radmanovi. Protective Effect of Hyperprolactinemia on Oxidative Stress in Patients with Psychotic Disorder on Atypical Antipsychotics Risperidone and Paliperidone: A Cross-Sectional Study. Biomedicines. vol 12. issue 7. 2024-07-27. PMID:39061992. |
protective effect of hyperprolactinemia on oxidative stress in patients with psychotic disorder on atypical antipsychotics risperidone and paliperidone: a cross-sectional study. |
2024-07-27 |
2024-07-29 |
Not clear |
| S Kor Spoelstra, Jojanneke Bruins, Leonie Bais, Paul Seerden, Stynke Castelein, Henderikus Knegterin. One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients', Relatives', and Mental Health Professionals' Perspectives. Patient preference and adherence. vol 16. 2022-03-14. PMID:35283623. |
one-month versus three-month formulation of paliperidone palmitate treatment in psychotic disorders: patients', relatives', and mental health professionals' perspectives. |
2022-03-14 |
2023-08-13 |
Not clear |
| Hormazd D Minwalla, Peter Wrzesinski, Allison Desforges, Joshua Caskey, Brittany Wagner, Patrick Ingraffia, James C Patterson, Amber N Edinoff, Adam M Kaye, Alan D Kaye, Omar Viswanath, Ivan Urit. Paliperidone to Treat Psychotic Disorders. Neurology international. vol 13. issue 3. 2021-08-30. PMID:34449689. |
paliperidone to treat psychotic disorders. |
2021-08-30 |
2023-08-13 |
Not clear |
| Miquel Bioque, Eduard Parellada, Clemente García-Rizo, Sílvia Amoretti, Adriana Fortea, Giovanni Oriolo, Pol Palau, Ester Boix-Quintana, Gemma Safont, Miquel Bernard. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study. European psychiatry : the journal of the Association of European Psychiatrists. vol 63. issue 1. 2021-04-13. PMID:32669145. |
clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: a retrospective 6-month mirror-image study. |
2021-04-13 |
2023-08-13 |
Not clear |
| Jaspinder Kaur, Dileep Kumar, Mostafa Alfishawy, Ricardo Lopez, Issac Sachmech. Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis. Case reports in critical care. vol 2016. 2020-10-01. PMID:27721999. |
we report a case of 35-year-old male with schizoaffective disorder who was admitted for acute-on-chronic exacerbation of his psychotic disorder for which intramuscular paliperidone 234 mg injection was given. |
2020-10-01 |
2023-08-13 |
Not clear |
| Robin Emsley, Eduard Parellada, Miquel Bioque, Berta Herrera, Teresa Hernando, Marta García-Dorad. Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies. International clinical psychopharmacology. vol 33. issue 1. 2018-07-18. PMID:28817397. |
the aim of this study was to perform a systematic review of the effects of 1-month paliperidone palmitate (pp1m) for the treatment of schizophrenia and related psychotic disorders in terms of outcomes reported in real-world evidence studies. |
2018-07-18 |
2023-08-13 |
Not clear |
| Robin Emsley, Eduard Parellada, Miquel Bioque, Berta Herrera, Teresa Hernando, Marta García-Dorad. Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies. International clinical psychopharmacology. vol 33. issue 1. 2018-07-18. PMID:28817397. |
real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies. |
2018-07-18 |
2023-08-13 |
Not clear |
| Madaswamy S Muthu, Ashish K Sahu, Sonali, Allabakshi Abdulla, Dhansukh Kaklotar, Chellappa V Rajesh, Sanjay Singh, Bajarangprasad L Pande. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug delivery. vol 23. issue 1. 2016-10-24. PMID:24853962. |
the objective of this work was to formulate paliperidone palmitate-loaded d-alpha-tocopheryl polyethylene glycol 1000 succinate (vitamin e tpgs or tpgs) micelles for improved antipsychotic effect during short-term management of psychotic disorders. |
2016-10-24 |
2023-08-13 |
Not clear |